Home I Privacy Policy I Terms Of Use I Contact Us
“This technology represents an exciting and important new treatment option for infertility.”
Dr. Leo Bonaventura, INVOcell Clinical Investigator and member of INVO Bioscience's Board of Advisors,
Bonaventura Reproductive Medicine, Carmel, member of INVO Bioscience's Board of Advisors.
"Based on my 28 years of experience in establishing human assisted reproduction in Latin America and the Caribbean, I believe the INVO Bioscience device has the potential to revolutionize the treatment of infertile couples in these countries. By providing an economical intermediate step between conventional insemination and an unaffordable conventional IVF treatment, the device should open up the opportunity to build a family to thousands of couples that have been economically disenfranchised from infertility therapies to date.”
Richard G. Rawlins, Ph.D., HCLD, ELD (ABB), Professor and Director IVF/ART Laboratories Dept OB/GYN,
Rush Centers for Advanced Reproductive Care, Rush University Medical Center, member of INVO
Bioscience's Board of Advisors.
“Patients who have done this have said that they like the fact that fertilization and embryo development is happening inside their body”
Dr. M, INVOcell Clinical Investigator
“Psychological factor for the patient should be taken into account. The rate of acceptance of intra vaginal culture was exceptionally high. Several couples reported great comfort in the feeling that there was no physical separation from the embryo as happens when culture takes place in the laboratory.”
Dr. S., IVC Researcher.
